People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for ...

Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more ...

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

Danish drugmaker Novo Nordisk is cutting U.S. supply on certain dose strengths of its highly sought-after weight loss drug Wegovy due to strong demand. Novo Nordisk – whose obesity care sales are ...

Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...

Credit: Getty Images. Wegovy is a glucagon-like peptide-1 receptor agonist. Certain dosage strengths of Wegovy (semaglutide) will be in short supply through September 2023, according to Novo Nordisk.

John Morton, M.D., M.P.H. Obesity / Health Care Policy Dr. John Morton is the system lead for surgical quality and bariatric services in the Yale New Haven Health System of six hospitals. He is also ...

Is your Wegovy real? Here’s how to ID fake weight loss drugs Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy ...